英文名稱 |
中文名稱 |
CAS號 |
操作 |
IBG3 |
|
|
詳細(xì)
|
BRD4 degrader-3 |
|
2413382-30-4 |
詳細(xì)
|
2,5-Dioxopyrrolidin-1-yl 3-(3-(but-3-yn-1-yl)-3H-diazirin-3-yl)propanoate |
2,5-DIOXOPYRROLIDIN-1-YL 3-(3-(BUT-3-YN-1-YL)-3H-DIAZIRIN-3-YL)PROPANOATE |
2012552-32-6 |
詳細(xì)
|
SB269970 HCl |
SB269970 HCl |
261901-57-9 |
詳細(xì)
|
SG3199 |
SG3199 |
1595275-71-0 |
詳細(xì)
|
CDK-IN-9 |
|
3031561-92-6 |
詳細(xì)
|
CP5V |
化合物 CP5V |
2509359-75-3 |
詳細(xì)
|
BAY-184 |
|
2520347-03-7 |
詳細(xì)
|
Methylphosphonsaeure-chlorid-isocyanat |
|
870-29-1 |
詳細(xì)
|
3,5-Difluoro-2-nitropyridine |
Pyridine, 3,5-difluoro-2-nitro- |
1073634-13-5 |
詳細(xì)
|
KAT6-IN-1 |
N-(6-((1H-吡唑-1-基)甲基)-4-甲氧基苯并[D]異惡唑-3-基)-2-甲氧基苯磺酰胺 |
2569008-99-5 |
詳細(xì)
|
BQZ-485 |
化合物 BQZ-485 |
1906915-49-8 |
詳細(xì)
|
NDI-101150 |
|
2628486-22-4 |
詳細(xì)
|
4-Chloro-N-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)benzamide |
|
697229-25-7 |
詳細(xì)
|
AB25583 |
|
2565637-94-5 |
詳細(xì)
|
MJ04 |
|
2099014-23-8 |
詳細(xì)
|
SMARt751 |
|
1616370-52-5 |
詳細(xì)
|
Oveporextonum |
|
2460722-04-5 |
詳細(xì)
|
PROTAC K-Ras Degrader-1 |
PROTAC K-RAS DEGRADER-1 |
2378258-52-5 |
詳細(xì)
|
BI-9774 |
|
1644498-53-2 |
詳細(xì)
|
PROTAC IRAK4 degrader-1 |
PROTAC IRAK4 degrader-1 |
2360533-90-8 |
詳細(xì)
|
PROTAC ERα Degrader-2 |
PROTAC ER Degrader-2 |
1351169-29-3 |
詳細(xì)
|
SS47 |
|
2636072-62-1 |
詳細(xì)
|
MS21 |
|
2376137-05-0 |
詳細(xì)
|
NRX2663 |
化合物 NRX-2663 |
2763260-34-8 |
詳細(xì)
|
MS-39 |
MS 39 |
2675490-92-1 |
詳細(xì)
|
PROTACBETdegrader-2 |
PROTAC BET DEGRADER-2 |
2093388-33-9 |
詳細(xì)
|
APX001 |
化合物 T23749 |
1169701-00-1 |
詳細(xì)
|
ONC213 |
|
1977540-13-8 |
詳細(xì)
|
Raseglurant/ADX-10059 |
2-[2-(3-FLUOROPHENYL)ETHYNYL]-4,6-DIMETHYL-3-PYRIDINAMINE |
757950-09-7 |
詳細(xì)
|
Linrodostat mesylate |
化合物 T4532L |
2221034-29-1 |
詳細(xì)
|
GSK_WRN4 |
|
2923008-66-4 |
詳細(xì)
|
SMARCA2 degrader-17 |
|
2755761-78-3 |
詳細(xì)
|
7030B-C5 |
8-[(2-羥基乙基)氨基]-7-(3-甲氧基芐基)-1,3-二甲基-1H-嘌呤-2,6(3H,7H)-二酮 |
370871-42-4 |
詳細(xì)
|
AUTAC2 |
|
2241669-08-7 |
詳細(xì)
|
PROTAC EZH2 Degrader-1 |
化合物 PROTAC EZH2 DEGRADER-1 |
2641601-67-2 |
詳細(xì)
|
PROTAC Sirt2 Degrader-1 |
2MG |
2098487-75-1 |
詳細(xì)
|
SMART1 |
|
|
詳細(xì)
|
MMP-2/MMP-9 Substrate |
MMP-2/MMP-9 SUBSTRATE II |
98992-65-5 |
詳細(xì)
|
Ladarixin/DF 2156A |
849776-05-2 |
849776-05-2 |
詳細(xì)
|
Physostigmine salicylate |
吡咯他尼雜質(zhì)A |
57-64-7 |
詳細(xì)
|
2938169-99-2 |
PAN-MUTATION KRAS PROTAC |
2938169-99-2 |
詳細(xì)
|
PW0464 |
PW0464 |
1643462-93-4 |
詳細(xì)
|
CBD3063 |
|
1281060-70-5 |
詳細(xì)
|
Girocitinibum |
|
2222137-79-1 |
詳細(xì)
|
LYMTAC-2 |
|
|
詳細(xì)
|
Lobeglitazone D4 |
洛貝格列酮 |
607723-33-1 |
詳細(xì)
|
Malaridine phosphate |
磷酸咯萘啶 |
74847-35-1 |
詳細(xì)
|
N-(4-Acetyl-5-(4-(3-(2,6-dimethylphenoxy)propoxy)phenyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide |
|
931741-35-4 |
詳細(xì)
|
Hv1 inhibitor HIF |
|
2247103-43-9 |
詳細(xì)
|
Pimonidazole hydrochloride |
PIMONIDAZOLE |
70132-51-3 |
詳細(xì)
|
BG-COOH |
|
881663-34-9 |
詳細(xì)
|
6-Benzyl-2-(2-(naphthalen-1-yl)acetamido)-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3-carboxamide hydrochloride |
|
1216723-84-0 |
詳細(xì)
|
Orniplabin |
化合物 ORNIPLABIN |
733805-92-0 |
詳細(xì)
|
FGN849 |
|
2069250-01-5 |
詳細(xì)
|
BRD4 ligand-Linker Conjugate 1 |
|
2154358-89-9 |
詳細(xì)
|
NA |
Sulfo-Cyanine5.5 amine/水溶性花菁染料Cy5-氨基 |
2183440-45-9 |
詳細(xì)
|
ZXH-4-130 TFA |
|
2711006-67-4 |
詳細(xì)
|
GSK121 |
GSK121 (trifluoroacetate salt) |
1652591-80-4 |
詳細(xì)
|
Sulfo-Cy5 diacid potassium |
CY5雙酸 |
252255-40-6 |
詳細(xì)
|
DYRKi |
化合物 T27226 |
1640364-04-0 |
詳細(xì)
|
Neoseptin 3 |
1622863-21-1 |
1622863-21-1 |
詳細(xì)
|
FluoroGold |
羥基脒雙(甲磺酸) |
223769-64-0 |
詳細(xì)
|
Acetyl tetrapeptide-2 acetate |
化合物ACETYL TETRAPEPTIDE-2 ACETATE |
2763584-38-7 |
詳細(xì)
|
LL-K12-18 |
|
|
詳細(xì)
|
CXM102 |
|
|
詳細(xì)
|
ZX782 |
|
|
詳細(xì)
|
N-((2S,3R)-4,4-difluoro-2-((2,3′,5′-trifluoro-[1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl)ethanesulfonamide hydrochloride |
|
2460728-34-9 |
詳細(xì)
|
(3E,7E)-4,8,12-Trimethyltrideca-3,7,11-trien-1-ol |
(3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-ol |
459-89-2 |
詳細(xì)
|
2434848-45-8 |
|
2434848-45-8 |
詳細(xì)
|
TAM inhibitor 2 |
TAM-IN-2 |
2135642-56-5 |
詳細(xì)
|
METTL1-WDR4-IN-2 |
化合物 METTL1-WDR4-IN-2 |
2919742-07-5 |
詳細(xì)
|
7-bromo-4-oxo-5-pivalamido-3,4-dihydrophthalazine-1-carboxylic acid |
|
2629317-74-2 |
詳細(xì)
|
1-(4-(4-Amino-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-3-(5-(1-(trifluoromethyl)cyclopropyl)isoxazol-3-yl)urea |
|
2731294-23-6 |
詳細(xì)
|
3-Hydroxyoctadecanoyl-L-carnitine in Methanol |
甲醇中3-羥基十八烷?;?L-肉堿 |
1469901-05-0 |
詳細(xì)
|
GLPG3312 |
化合物 GLPG3312 |
2340388-72-7 |
詳細(xì)
|
N-[[4-(Morpholin-4-ylmethyl)phenyl]methyl]thieno[2,3-d]pyrimidin-4-amine |
|
92416-07-7 |
詳細(xì)
|
(S)-Ornidazole |
左旋奧硝唑 |
166734-83-4 |
詳細(xì)
|
Biotin-BMCC |
(3AS,4S,6AR)-N-[4-[[[4-[(2,5-二氫-2,5-二氧代-1H-吡咯-1-基)甲基]環(huán)己基]羰基]氨基]丁基]六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-戊酰胺 |
188682-72-6 |
詳細(xì)
|
NUC-3373 |
NUC-3373 |
1332837-31-6 |
詳細(xì)
|
APF |
APF |
359010-70-1 |
詳細(xì)
|
Revexepride |
219984-49-3 |
219984-49-3 |
詳細(xì)
|
Deruxtecan analog 2 |
化合物 DERUXTECAN ANALOG 2 |
1599440-10-4 |
詳細(xì)
|
2H-Pyran-2-acetonitrile, tetrahydro-5-(2-methyl-1H-furo[3,2-b]imidazo[4,5-d]pyridin-1-yl)-, (2R,5S)- |
(2R,5S)-四氫-5-(2-甲基-1H-呋喃并[3,2-B]咪唑并[4,5-D]吡啶-1-基)-2H-吡喃-2-乙腈 |
2222137-86-0 |
詳細(xì)
|
A947 |
|
2378056-80-3 |
詳細(xì)
|
CDK2-IN-30 |
|
2640038-22-6 |
詳細(xì)
|
AT-0174 |
|
|
詳細(xì)
|
DHX9-IN-9 |
|
2973400-46-1 |
詳細(xì)
|
PROTAC IRAK3 degrade-1 |
PROTAC IRAK3 DEGRADE-1 |
2712600-00-3 |
詳細(xì)
|
NDI-101150 |
|
2628486-21-3 |
詳細(xì)
|
PKMYT1-IN-3 |
|
|
詳細(xì)
|
AZ'3137 |
|
2960179-55-7 |
詳細(xì)
|
MK2-IN-4 |
化合物 MK2-IN-4 |
1105658-32-9 |
詳細(xì)
|
IL-23R inhibitor peptide-1 |
抑制劑多肽IL-23R INHIBITOR PEPTIDE-1 |
2894052-23-2 |
詳細(xì)
|
GSK2163632A |
化合物 T24106 |
1123163-20-1 |
詳細(xì)
|
DSP5336 |
|
|
詳細(xì)
|
JNJ-8003 |
|
|
詳細(xì)
|
MS6105 |
|
2891709-58-1 |
詳細(xì)
|
PROTAC BRD4 Degrader-12 |
|
2417370-90-0 |
詳細(xì)
|
PROTAC KRAS G12C degrader-2 |
|
2378257-72-6 |
詳細(xì)
|